Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 26, No 21 (July 20), 2008: pp. 3536-3542
© 2008 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.14.4899

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hayes, S. C.
Right arrow Articles by Newman, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hayes, S. C.
Right arrow Articles by Newman, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body Function

Sandra C. Hayes, Monika Janda, Bruce Cornish, Diana Battistutta, Beth Newman

From the Institute of Health and Biomedical Innovation, School of Public Health; and School of Physical and Chemical Sciences, Queensland University of Technology, Kelvin Grove, Queensland, Australia

Corresponding author: Sandra Hayes, MD, Institute of Health and Biomedical Innovation, School of Public Health, Faculty of Health, Queensland University of Technology, Victoria Park Rd, Kelvin Grove, QLD 4059, Australia; e-mail: sc.hayes{at}qut.edu.au

Purpose Secondary lymphedema is associated with adverse physical and psychosocial consequences among women with breast cancer (BC). This article describes the prevalence and incidence of lymphedema between 6 and 18 months after BC treatment; personal, treatment, and behavioral correlates of lymphedema status; and the presence of other upper-body symptoms (UBS) and function (UBF).

Patients and Methods A population-based sample of Australian women (n = 287) with recently diagnosed, invasive BC were evaluated on five occasions using bioimpedance spectroscopy. Lymphedema was diagnosed when the ratio of impedance values, comparing treated and untreated sides, was three standard deviations more than normative data. UBF was assessed using the validated Disability of the Arm, Shoulder, and Hand questionnaire.

Results From 6 to 18 months after surgery, 33% (n = 62) of the sample were classified as having lymphedema; of these, 40% had long-term lymphedema. Although older age, more extensive surgery or axillary node dissection, and experiencing one or more treatment-related complication(s) or symptom(s) at baseline were associated with increased odds, lower socioeconomic status, having a partner, greater child care responsibilities, being treated on the dominant side, participation in regular activity, and having good UBF were associated with decreased odds of lymphedema. Not surprisingly, lymphedema leads to reduced UBF; however, BC survivors report high prevalences of other UBS (34% to 62%), irrespective of their lymphedema status.

Conclusion Lymphedema is a public health issue deserving greater attention. More systematic surveillance for earlier detection and the potential benefits of physical activity to prevent lymphedema and mitigate symptoms warrant further clinical integration and research.

Supported by the National Breast Cancer Foundation (NBCF; funding for the Pulling Through Study) and Johnson and Johnson (contributions to NBCF to fund the fellowship of S.C.H.).

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
S. C. Hayes, M. Janda, B. Cornish, and B. Newman
Lymphedema Following Breast Cancer
J. Clin. Oncol., June 10, 2009; 27(17): 2890 - 2890.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
W. P. Dunworth and K. M. Caron
G Protein-Coupled Receptors as Potential Drug Targets for Lymphangiogenesis and Lymphatic Vascular Diseases
Arterioscler. Thromb. Vasc. Biol., May 1, 2009; 29(5): 650 - 656.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
Y.-C. T. Shih, Y. Xu, J. N. Cormier, S. Giordano, S. H. Ridner, T. A. Buchholz, G. H. Perkins, and L. S. Elting
Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study
J. Clin. Oncol., April 20, 2009; 27(12): 2007 - 2014.
[Abstract] [Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Learning More About Lymphedema After Breast Cancer Surgery
Journal Watch Women's Health, September 4, 2008; 2008(904): 4 - 4.
[Full Text]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online